IPO registrations (S-1, F-1) · Registrants
Stereotaxis, Inc.
- SEC CIK
- 1289340 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2004-05-07, last 2016-11-10; 6 initial registrations, 17 amendments
- Outcome
- Final prospectus filed 2004-08-12; declared effective 2006-09-07
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 710 N TUCKER BLVD, STE 110, St.louis, MO 63101
- EIN
- 94-3120386
- Ticker
- STXS (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Stereotaxis, Inc. on the corporate pages
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2004-08-11)
- Final price
- $8.00 per share, within the range (424B4 filed 2004-08-12, an initial public offering)
- Shares sold
- 5,500,000
- Gross proceeds
- $44,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol STXS
- Lead underwriters
- Goldman Sachs (2,750,000 shares)
- Syndicate
- Bear Stearns (1,650,000); Deutsche Bank (825,000); A.G. Edwards (275,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: STEREOTAXIS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Stereotaxis, Inc. Fuzzy (name and state)
- Business registration: STEREOTAXIS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: STEREOTAXIS, INC. EXACT (EIN (EXACT))
- Federal award recipient: STEREOTAXIS, INC Fuzzy (name and state)
- Form D issuer: Stereotaxis, Inc. EXACT (CIK (EXACT))
- SEC filer: Stereotaxis, Inc. EXACT (CIK (EXACT))
- Person page: Ralph G Dacey Jr Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Ross B Levin Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 41
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-05-07 | S-1 | S-1 (registration) | Stereotaxis, Inc. | 0000950137-04-003673 ↗ |
| 2004-05-12 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950137-04-003982 ↗ |
| 2004-06-17 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950137-04-004922 ↗ |
| 2004-07-01 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950137-04-005432 ↗ |
| 2004-07-12 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950137-04-005554 ↗ |
| 2004-07-16 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950134-04-010128 ↗ |
| 2004-07-26 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950137-04-005849 ↗ |
| 2004-08-03 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950137-04-006142 ↗ |
| 2004-08-11 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0000950137-04-006552 ↗ |
| 2004-08-12 | 424B4 | 424B4 (final prospectus) | Stereotaxis, Inc. | 0000950137-04-006694 ↗ |
| 2006-09-07 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-06-001455 ↗ |
| 2006-09-07 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-06-001456 ↗ |
| 2009-09-15 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-09-002564 ↗ |
| 2009-09-15 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-09-002565 ↗ |
| 2012-05-23 | S-1 | S-1 (registration) | Stereotaxis, Inc. | 0001193125-12-245068 ↗ |
| 2012-06-11 | S-1 | S-1 (registration) | Stereotaxis, Inc. | 0001193125-12-266854 ↗ |
| 2012-07-19 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-12-307438 ↗ |
| 2012-07-19 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-12-307451 ↗ |
| 2012-08-01 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-12-328739 ↗ |
| 2012-08-01 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-12-328762 ↗ |
| 2012-08-03 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-12-002374 ↗ |
| 2012-08-03 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-12-002375 ↗ |
| 2012-08-17 | S-1 | S-1 (registration) | Stereotaxis, Inc. | 0001193125-12-360918 ↗ |
| 2012-08-29 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-12-374144 ↗ |
| 2012-08-31 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-12-002644 ↗ |
| 2013-04-08 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-13-000916 ↗ |
| 2013-04-08 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-13-000917 ↗ |
| 2013-04-08 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-13-000919 ↗ |
| 2013-09-09 | S-1 | S-1 (registration) | Stereotaxis, Inc. | 0001193125-13-360512 ↗ |
| 2013-10-09 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-13-395281 ↗ |
| 2013-10-23 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-13-407418 ↗ |
| 2013-10-24 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-13-409084 ↗ |
| 2013-10-29 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-13-003101 ↗ |
| 2013-12-11 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-13-003533 ↗ |
| 2014-05-06 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-14-001340 ↗ |
| 2014-05-06 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-14-001341 ↗ |
| 2014-05-06 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-14-001342 ↗ |
| 2016-10-26 | S-1 | S-1 (registration) | Stereotaxis, Inc. | 0001193125-16-747705 ↗ |
| 2016-11-10 | S-1/A | S-1/A (amendment) | Stereotaxis, Inc. | 0001193125-16-766069 ↗ |
| 2016-11-15 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-16-006239 ↗ |
| 2018-05-31 | EFFECT | EFFECT (declared effective) | Stereotaxis, Inc. | 9999999995-18-001381 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-08-11 | S-1/A | registration statement | $8.00–$10.00 | 5,000,000 | - | Nasdaq STXS | 5 | primary document; range, shares headline, underwriting table 1, cover names 4 | document ↗ | |
| 2004-08-12 | 424B4 | final prospectus | $8.00 | 5,500,000 | $44,000,000 | Nasdaq STXS | 4 | primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Mills William C. III | Director; Director,Officer | Chief Executive Officer; Interim CEO | 33 | 2006–2016 | |
| Bruce Douglas Michael | Director,Officer; Officer | Cheif Tech/Operations Officer; Chief Tech./Operations Officer; Chief Tech/Operations Officer; Sr. VP, Research & Development | 16 | 2006–2012 | |
| Hogg Bevil J | Director; Director,Officer | CEO; Chief Executive Officer; President & CEO | 17 | 2006–2010 | |
| Kaminski Michael P | Director,Officer; Officer | Chief Operating Officer; President and CEO; President & CEO; President & COO | 31 | 2006–2013 | |
| Sehra Ruchir | Officer | Chief Medical Officer | 3 | 2006 | |
| STOLZE JAMES M | Officer | V.P. & CFO | 9 | 2006–2009 | |
| Walker Melissa | Officer | Sr. VP, Reg., Quality & Comp.; Sr. VP, Reg., Quality & Compl.; SVP, Reg, Quality & Compliance; VP, Regulatory & Quality | 15 | 2006–2010 | |
| MESSEY ROBERT J | Director | 29 | 2006–2024 | ||
| ACHARYA ABHI | Director | 4 | 2006–2008 | ||
| Alafi Christopher D | Director; Director,TenPercentOwner; TenPercentOwner | 34 | 2006–2013 | ||
| Benfer David | Director | 43 | 2006–2026 | ||
| Dacey Ralph G Jr | Director | 3 | 2006–2008 | person page Fuzzy | |
| Johnson Gregory R | Director | 5 | 2006–2007 | ||
| Kelley William M | Director | 11 | 2006–2012 | ||
| Lele Abhijeet J | Director | 9 | 2006–2010 | ||
| MIDDLETON FRED A | Director; Director,TenPercentOwner | 57 | 2006–2018 | ||
| ALAFI CAPITAL CO LLC | TenPercentOwner | 2 | 2006–2007 | ||
| ALAFI MOSHE | TenPercentOwner | 2 | 2006–2007 | ||
| PRYSTOWSKY ERIC N | Director | 14 | 2007–2016 | ||
| HARADA LUKE | Officer | Sr. VP, Business Development | 2 | 2007 | |
| SHIFRIN KEVIN T | Officer | Sr. VP, Marketing & Bus. Dev. | 3 | 2008 | |
| RUGGIERO LOUIS T | Officer | Chief Commercial Officer; Sr. V.P., North America | 5 | 2008–2009 | |
| JOHNSTON DANIEL J | Officer | CFO; Chief Financial Officer | 5 | 2009–2011 | |
| Cheng Frank | Officer | Senior VP, Marketing and BD | 24 | 2010–2016 | |
| Giffin David | Officer | VP, Human Resources | 29 | 2010–2017 | |
| Duros Karen Witte | Officer | Sr. VP, Gen. Counsel and Sec.; Sr. VP, Gen. Counsel, and Sec.; Sr. VP, Gen. Counsel & Sec. | 28 | 2010–2018 | |
| KEEGAN JOSEPH D | Director | 9 | 2011–2016 | ||
| Stammer Martin C | Officer | Chief Financial Officer; Corporate Controller and PAO; PFO, PAO and Interim CFO | 28 | 2011–2019 | |
| Duggan Samuel W II | Officer | Chief Financial Officer | 6 | 2011–2012 | |
| Thomson Euan | Director | 6 | 2012–2016 | ||
| DeSisto Duane | Director | 4 | 2015–2016 | ||
| Brathwaite Paul | Officer | Section 16 Officer; VP Research & Development | 10 | 2015–2018 | |
| Fischel David Leo | Director; Director,Officer | Chief Executive Officer | 11 | 2016–2021 | |
| KIANI JOE E | Director; Director,TenPercentOwner | 11 | 2016–2021 | ||
| Menawat Arun Swarup | Director | 23 | 2016–2026 | ||
| Fischel Nathan | Director; Director,TenPercentOwner | 22 | 2017–2026 | ||
| DAFNA Capital Management LLC | TenPercentOwner | 1 | 2018 | ||
| Ghodsian Fariba Fischel | TenPercentOwner | 1 | 2018 | ||
| Isaac Paul J | Director,Other; DirectorOther; TenPercentOwner | 53 | 2018–2025 | ||
| Levin Ross B | Director | 18 | 2018–2026 | person page Fuzzy | |
| Barry Kevin M. | Officer | Chief Legal Officer & Secretar; Chief Legal Officer&Secretary | 3 | 2018–2019 | |
| Peery Kimberly R. | Officer | Chief Financial Officer | 9 | 2019–2026 | |
| Curet Myriam | Director | 11 | 2021–2026 | ||
| SHAMIR NACHUM | Director | 5 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-08-15 | Stereotaxis, Inc. | Other Technology | Indefinite | $3,000,000 | 1 | 1 |
| 2019-08-21 | Stereotaxis, Inc. | Other Technology | $25,000,000 | $25,000,000 | 6 | 1 |
| 2016-10-05 | Stereotaxis, Inc. | Other Technology | $24,000,000 | $24,000,000 | 12 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Stereotaxis, Inc. | MO | State business registries | name and state |
| Business registration | STEREOTAXIS, INC. | MO | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | STEREOTAXIS, INC. | MO | State business registries | name and state |
| Federal award recipient | STEREOTAXIS, INC | MO | Federal spending (USAspending) | name and state |
| Form D issuer | Stereotaxis, Inc. | MO | Form D private offerings | CIK (EXACT) |
| Paying company | Stereotaxis Inc | MO | Open Payments (drug and device company payments) | name and state |
| Patent assignee | STEREOTAXIS, INC. | MO | Patents (USPTO) | name and state |
| SEC filer | Stereotaxis, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Stereotaxis, Inc. | MO | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | STEREOTAXIS, INC. | EIN (EXACT) | ||
| Person page | Ralph G Dacey Jr | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Ross B Levin | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, MO first:
- ENDOSTIM, INC. MO
- Medisun Precision Medicine Ltd. 1T
- Solta Medical Corp A8
- ULTHERA INC AZ
- CardieX Ltd C3
- BeneChill, Inc. ca
- ENDOCARE INC CA
- IMAGYN MEDICAL INC CA
- CARDIAC PATHWAYS CORP CA
- ARADIGM CORP CA
In other datasets, the same topic (Technology) in MO:
- Form D issuer: 4ME4WE LLC (Form D private offerings)
- Lobbying client: 321 STUDIOS (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology